Gainers
- Sierra Oncology, Inc. SRRA shares increased by 43.3% to $0.55 during Friday's pre-market session. The market cap stands at $23.1 million. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.
- Cassava Sciences, Inc. SAVA stock moved upwards by 40.6% to $2.53. The market value of their outstanding shares is at $20.6 million.
- Puma Biotechnology, Inc. PBYI stock increased by 5.9% to $7.88. The market cap seems to be at $264.8 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $8.00.
- Celyad, Inc. CYAD stock rose 4.3% to $12.58. The market cap seems to be at $135.9 million.
- Sage Therapeutics, Inc. SAGE stock rose 2.4% to $61.64. The market value of their outstanding shares is at $7.0 billion. According to the most recent rating by SVB Leerink, on December 06, the current rating is at Market Perform.
Losers
- Sienna Biopharmaceuticals, Inc. SNNA stock plummeted 13.1% to $0.20 during Friday's pre-market session. The market cap stands at $5.4 million.
- Bionano Genomics, Inc. BNGO stock declined 5.5% to $1.03. The market cap stands at $20.9 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
